Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP, close the discussion with key takeaways for payers to consider related to ruxolitinib and insights on future research.
COBRA coverage is not currently considered creditable coverage, so some seniors face Part B penalties. That needs to change.
Now is the time to take serious action to reform wasteful hospital practices and strengthen the healthcare supply chain. The high cost of American healthcare has topped headlines for years.
An expert discusses considerations for tailoring narcolepsy treatment plans for patients with complex comorbidities or lifestyle needs, the role of insurance policies, prior authorizations, and specialty pharmacies in treatment access, emerging strategies to improve care in underserved populations, and the role of hypocretin in narcolepsy.
Facing a variety of financial pressures, health plans need to take a measured approach to identify supplemental benefit strategies that facilitate their success.
A forecast for this year by Luis E. Taveras, Ph.D., senior vice president and chief information officer of Lehigh Valley Health Network.
How consumers feel about their virtual care encounters will influence everything from CAHPS surveys to compensation beyond the pandemic.
The new model starts in July 2023. Practices will be required to take on two-sided risk right from the start.
In the post-pandemic future, we will likely see that hybrid patient care models are the norm. As hospitals and health systems plan for this shift, they’ll need to consider two critical factors.
A recent study presents a unique case of sudden-onset vitiligo following the COVID-19 vaccination, along with a systematic review of existing literature to shed light on the potential link between vaccination and vitiligo development.
Many healthcare organizations find themselves in arrangements with technology vendors in which patient-reported outcomes measures are handled as an add-on to an existing electronic health records. The better way makes it easier and more convenient for patients to supply information and incentivizes engagement.
Kenan R. Omurtag, M.D., discusses how addressing unique needs of LGBTQ patients involves tailored fertility treatments and legal considerations, while emphasizing the importance of early fertility preservation counseling and expedited procedures for cancer patients, including cryopreservation of eggs, sperm or embryos prior to potentially gonadotoxic treatments.
Identifying what is truly treatment resistant depression is difficult given all the factors that may influence how a person responds to treatment.
The complexity of the phased approach to COVID-19 vaccination will require strategic use of data and communication.
Future interventions for improving disparities should be aimed at improving overall access to care for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Significant attention has been paid to the recent surge in telehealth. This attention is valid. While usage of telehealth has declined from the initial months of the pandemic, FAIR Health data show that telehealth claim lines had increased more than 2,800% nationally from December 2019 to December 2020.
Chronic insomnia has been linked to a variety of mental and physical illnesses. Researchers have found that cognitive behavioral therapy is often effective.
Medicare and Medicaid programs that serve the most-vulnerable Americans facing SDOH barriers can be major facilitators of appropriate non-emergency transportation to non-medical sites. But how do we determine what is appropriate, and what do we know about transportation services to non-medical sites today?
To make patient-generated health data work for clinicians, health information technology vendors must effectively integrate this patient-generated data into clinical workflows in a way that helps clinicians do their jobs more efficiently and effectively.
François de Brantes, a member of the Managed Healthcare Executive ® editorial advisory board and senior partner at High Value Care Incentives Advisory Group LLC, describes what he believes has caused a major inflection point in the management, delivery and payment of U.S. healthcare
Amid continued hospital growth and expansion, ensuring common access to research capabilities and technology across the entire network of a health system is necessary for clinical trial success.
The coronavirus pandemic has shed light on major imbalances within the healthcare system, specifically, the supply and demand of allied health professionals, and the urgent need to invest in community-based care that prioritizes vulnerable populations.
To truly transform healthcare, we must create a connected care journey: delivering care that meets patients where they are, when they need it, and continues to be personalized for them through their entire health journey, wherever that may lead next.
An expert in endocrinology reviews updates from the AMCP Nexus 2021 conference on treatment persistence and adherence with iGlarLixi versus free-dose combinations of basal insulin and GLP-1 receptor agonists, and shares insight on future directions for disease management.
The speed of adoption of new practices in medicine is extremely slow. We need systems to test new protocols, make sure they’re safe and effective, and get them out into the world more rapidly.
It will be vital for providers of healthcare to consider whether innovations truly improve people’s lives and make care more efficient, or will they just be another layer on the workflow and take clinicians’ time away from patients.
Healthcare HR professionals—if they haven’t already—must reshape the workplace each and every day by focusing intently and with new eyes on what matters most during this ongoing pandemic: employees.
In a 10-year study in patients vaccinated with Gardasil 9, no cases of HPV-related cancers or genital warts were seen.